©The Author(s) 2025.
World J Gastroenterol. Dec 14, 2025; 31(46): 111176
Published online Dec 14, 2025. doi: 10.3748/wjg.v31.i46.111176
Published online Dec 14, 2025. doi: 10.3748/wjg.v31.i46.111176
Table 2 Artificial intelligence-augmented vs human-only diagnostic accuracy: Current evidence
| Task | AI model/dataset | AI performance | Comparator | Outcome |
| CT-based HCC detection[6] | CNN on CT (deep segmentation, auto segment) | Sensitivity approximately 92%, specificity approximately 97% | Radiologists | Outperformed (AI Sn/Sp 92/98 vs 82.5/96.5); supports workflow |
| PLAN-B-DF (internal/external validation)[70] | Auto segmentation + clinical data | C-index 0.91; 0.89 | Traditional risk scores | Outperformed |
| Ultrasound focal lesion detection[81] | DL on B-mode US | AUC approximately 0.93 | Sonographers | Comparable performance |
| Radiomics MVI in HCC[82] | Deep learning (large meta analysis) | AUC approximately 0.97 | Non-DL ML (AUC 0.82) | DL superior |
| Histopathology slide review[38] | DL assistance | Accuracy approximately 0.885 | Pathologists | Assisted improvements but risks of misguidance noted |
- Citation: Sun JR, Sun XN, Lu BJ, Deng BC. Artificial intelligence in hepatopathy diagnosis and treatment: Big data analytics, deep learning, and clinical prediction models. World J Gastroenterol 2025; 31(46): 111176
- URL: https://www.wjgnet.com/1007-9327/full/v31/i46/111176.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i46.111176